Physician profile
Robert J Dausch
NPI 1528046851
$1,515.08
in general payments reported to CMS, 2019-2025
16 companies · $341 in 2025
The $341 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.52 · 2020: $24.63 · 2021: $269 · 2022: $338 · 2023: $266 · 2024: $262 · 2025: $341.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $868.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $868.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $948.35 | 2021-2025 | Vraylar, Ubrelvy, Qulipta |
| Pfizer INC. | $104.81 | 2023-2025 | |
| Novo Nordisk INC | $104.33 | 2021-2025 | |
| Glaxosmithkline, LLC. | $91.17 | 2020-2023 | Shingrix, Arexvy |
| Boston Scientific Corporation | $37.24 | 2025 | Watchman Flx |
| Lilly USA, LLC | $36.61 | 2022 | |
| Janssen Pharmaceuticals, INC | $30.51 | 2021-2022 | |
| Amgen INC. | $29.05 | 2021-2023 | Repatha |
| Sumitomo Pharma America, INC. | $22.23 | 2025 | Gemtesa |
| Philips North America LLC | $21.81 | 2024 | (Ck6) Holter |
| Almatica Pharma LLC | $16.30 | 2022 | |
| Medtronic, INC. | $16.14 | 2022 | |
| Abbott Laboratories | $15.52 | 2019 | |
| Edwards Lifesciences Corporation | $15.10 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Biohaven Pharmaceutical Holding Company LTD. | $14.09 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $11.82 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Dausch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.